Evaluation of the clinical efficacy of Shenshuaining capsule in the treatment of end-stage renal disease with peritoneal dialysis

The First Affiliated Hospital of Chengdu Medical College0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Aged over 18 years male and female;
•2. Clear consciousness;
•3. Regular peritoneal dialysis was performed and the urine volume was > 100ml at 24 hours;
•4. Patients with stable condition who insist on regular review of relevant indicators every 3 months;
•5. Volunteer to participate in this study and sign the informed consent;
•6. Chinese medicine dialectic is the spleen of the spleen or the spleen and blood bruising.

•1. Allergic constitution or allergic to a variety of drugs;
•2. There are serious digestive tract diseases that affect drug absorption,such as active ulcer,Chronic diarrhea,etc.;
•3. A woman who is pregnant or breast-feeding;
•4. Inability to cooperate, as with a psychopath;
•5. Alcohol or drug abusers;
•6. Patients who had been given Niaoduqing Particles before enrollment;
•7. Drugs containing rhubarb were used before enrollment or during the trial.

发起方